Insight 2811, Inc. Merck & Co., Inc. Transaction History

Insight 2811, Inc.

$199 Million
Q3 2024

A detailed history of Insight 2811, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Insight 2811, Inc. holds 7,503 shares of MRK stock, worth $744,147. This represents 0.43% of its overall portfolio holdings.

Number of Shares

7,503

Previous 7,468 0.47%

Holding current value

$744,147

Previous $924,000 7.79%

% of portfolio

0.43%

Previous 0.48%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$111.15 - $128.97 $3,890 - $4,513	35 Added 0.47%	7,503 $852,000
Q2 2024 Aug 06, 2024	SELL	$123.8 - $132.96 $5,199 - $5,584	-42 Reduced 0.56%	7,468 $924,000
Q1 2024 May 06, 2024	BUY	$113.24 - $131.95 $1,698 - $1,979	15 Added 0.2%	7,510 $990,000
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $45,281 - $49,277	-452 Reduced 5.69%	7,495 $817,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $120,966 - $134,337	-1,175 Reduced 12.88%	7,947 $818,000
Q2 2023 Aug 04, 2023	SELL	$108.61 - $118.38 $13,467 - $14,679	-124 Reduced 1.34%	9,122 $1.05 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $12,970 - $14,472	-126 Reduced 1.34%	9,246 $983,000
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $94,959 - $121,751	1,086 Added 13.11%	9,372 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $7,438 - $8,356	88 Added 1.07%	8,286 $714,000
Q2 2022 Aug 09, 2022	SELL	$83.49 - $94.64 $8,349 - $9,464	-100 Reduced 1.21%	8,198 $747,000
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $22,420 - $25,132	305 Added 3.82%	8,298 $681,000
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $7,878 - $9,868	109 Added 1.38%	7,993 $613,000
Q3 2021 Nov 04, 2021	SELL	$71.68 - $78.83 $50,176 - $55,181	-700 Reduced 8.15%	7,884 $592,000
Q2 2021 Aug 04, 2021	BUY	$70.31 - $77.77 $15,819 - $17,498	225 Added 2.69%	8,584 $668,000
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $15,080 - $17,763	219 Added 2.69%	8,359 $644,000
Q4 2020 Jan 29, 2021	SELL	$71.77 - $79.65 $4,306 - $4,779	-60 Reduced 0.73%	8,140 $666,000
Q3 2020 Oct 20, 2020	SELL	$73.18 - $82.95 $21,954 - $24,885	-300 Reduced 3.53%	8,200 $680,000
Q2 2020 Jul 21, 2020	SELL	$70.42 - $80.13 $56,336 - $64,104	-800 Reduced 8.6%	8,500 $665,000
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $329,472 - $456,663	5,200 Added 126.83%	9,300 $716,000
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $31,032 - $35,016	-400 Reduced 8.89%	4,100 $373,000
Q3 2019 Oct 31, 2019	SELL	$76.08 - $82.93 $121,728 - $132,688	-1,600 Reduced 26.23%	4,500 $379,000
Q2 2019 Jul 09, 2019	BUY	$69.84 - $81.59 $230,472 - $269,247	3,300 Added 117.86%	6,100 $530,000
Q4 2018 Feb 25, 2019	BUY	$65.24 - $75.71 $182,672 - $211,987	2,800 New	2,800 $214,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight 2811, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Insight 2811, Inc. with notifications on news.

Account